All Articles

A star-studded concert in Latvia wasn't just a party. It was a masterclass in soft power, revealing the invisible infrastructure of security and private capital.

McDermott Will & Schulte's hire of a top PE lawyer isn't just a personnel move. It's the capstone of a decade-long strategy to conquer New York.

A Utah biotech is deploying UAE genomics and a novel drug to mimic natural immunity to Alzheimer's, signaling a strategic shift to precision prevention.

The appointment of Irvinder Singh Lail signals a strategic shift, aiming to unify global talent and AI to master the complex, high-stakes consulting market.

Chesapeake Utilities is doubling down on the Sunshine State with a massive natural gas pipeline. But is this $1.2 billion project a masterstroke or a risky gamble?

An exclusive deal makes high-resolution aerial imagery a new global standard, embedding a single source of truth into the systems that run our cities.

Ocugen inks a potential $255M+ deal to bring its OCU400 gene therapy for Retinitis Pigmentosa to the MENA region, a strategic move into a high-need market.

A new partnership between Spear Education and Kwikly is moving beyond temp staffing, betting that upskilling hygienists is the key to practice growth.

Fastmail's new EU data center isn't just about faster email. It's a strategic play for data sovereignty, challenging Big Tech's cloud-first model.

With the appointment of Kyle Otting, a seasoned leader in reusable logistics, Rebox Corp is signaling a major push to scale its disruptive model for used boxes.

A Canadian waste firm's quiet Michigan acquisition signals a major shift. Backed by BlackRock, E360S is building a North American environmental network.

Delonix Bioworks is running parallel trials in China and Australia for its MenB vaccine, a strategic gambit that could disrupt a billion-dollar market.

AT&T offers free calls for the World Cup finals, but the real story isn't goodwill. It's a strategic move to showcase network dominance and public safety integration.

Fresh from a 2020 bankruptcy, the menswear giant behind Men's Wearhouse is going public. Can it convince Wall Street that suits and stores have a future?

New research reveals a popular brain training app may reduce key Alzheimer's biomarkers, offering a potential non-drug path to combat neurodegeneration.

In a major corporate governance showdown, all three top proxy advisory firms have sided with Genesco's board, validating its strategy and rebuffing activist Bradley Radoff.

ProCap Financial's AI agent has amassed $50B in user assets, signaling a new era for investors. But beyond the hype, what are the real gains and risks?

With its new FDA-cleared Osia 3, Cochlear isn't just launching a rechargeable device. It's executing a strategic overhaul of the user experience and service delivery.

Enterprise AI firm Zip opens a major hub in NYC's former Twitter building, signaling a shift in the tech world and a revolution in corporate spending.

Amid key technical wins like piloted transition, Vertical Aerospace delays its eVTOL certification, a move reflecting an industry-wide reality check.